Position in AMGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,865,642
+$37,430 QoQ
Shares Held
5,152
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,312
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $28,439,814 across 10 Drug Manufacturers - General names. AMGN ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,607 | $13,921,785 | |
| 2 | JNJ |
Johnson & Johnson
|
23,878 | $6,064,295 | |
| 3 | ABBV |
AbbVie Inc.
|
9,748 | $2,452,986 | |
| 4 | AMGN |
Amgen Inc
This page
|
5,152 | $1,865,642 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,070 | $1,422,495 | |
| 6 | PFE |
Pfizer Inc
|
56,869 | $1,369,405 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,040 | $520,884 | |
| 8 | NVS |
Novartis AG
|
2,430 | $380,829 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,865,642 | 5,152 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,828,212 | 5,196 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,747,508 | 5,339 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,782,657 | 6,317 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,173,370 | 7,784 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,425,105 | 7,784 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,906,842 | 7,316 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $2,282,857 | 7,085 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,204,647 | 7,056 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,834,148 | 6,451 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $700,752 | 2,433 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $703,613 | 2,618 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $567,261 | 2,555 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $612,111 | 2,532 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $664,741 | 2,531 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $570,262 | 2,530 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $620,171 | 2,549 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $561,022 | 2,320 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $534,528 | 2,376 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $495,687 | 2,331 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $573,056 | 2,351 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $660,590 | 2,655 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $610,437 | 2,655 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $674,794 | 2,655 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $637,529 | 2,703 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $553,047 | 2,728 | Shares | Sole | 2020-06-01 | |
| No filing history on record for this holder in this stock. | ||||||